IL68201A0 - Peptides with the specificity of foot and mouth disease viral antigens and compositions and methods for treating animals using the same - Google Patents
Peptides with the specificity of foot and mouth disease viral antigens and compositions and methods for treating animals using the sameInfo
- Publication number
- IL68201A0 IL68201A0 IL68201A IL6820183A IL68201A0 IL 68201 A0 IL68201 A0 IL 68201A0 IL 68201 A IL68201 A IL 68201A IL 6820183 A IL6820183 A IL 6820183A IL 68201 A0 IL68201 A0 IL 68201A0
- Authority
- IL
- Israel
- Prior art keywords
- peptides
- specificity
- foot
- compositions
- methods
- Prior art date
Links
- 208000007212 Foot-and-Mouth Disease Diseases 0.000 title 1
- 241000710198 Foot-and-mouth disease virus Species 0.000 title 1
- 241001465754 Metazoa Species 0.000 title 1
- 239000000427 antigen Substances 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 230000003612 virological effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
- C12N2770/32122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
- C12N2770/32134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/806—Antigenic peptides or proteins
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/22—Viral peptide or viral protein
- Y10S930/222—Foot and mouth disease related
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Virology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB8209041 | 1982-03-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
IL68201A0 true IL68201A0 (en) | 1983-06-15 |
Family
ID=10529329
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL68201A IL68201A0 (en) | 1982-03-26 | 1983-03-23 | Peptides with the specificity of foot and mouth disease viral antigens and compositions and methods for treating animals using the same |
Country Status (10)
Country | Link |
---|---|
US (1) | US4605512A (fr) |
EP (1) | EP0090581A3 (fr) |
JP (1) | JPS58213723A (fr) |
AU (1) | AU1255383A (fr) |
DK (1) | DK139083A (fr) |
ES (1) | ES8500997A1 (fr) |
IL (1) | IL68201A0 (fr) |
NO (1) | NO831098L (fr) |
PT (1) | PT76451B (fr) |
ZA (1) | ZA831854B (fr) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3382459D1 (de) * | 1982-04-14 | 1991-12-19 | James L Bittle | Kuenstliches pikornavirusantigen. |
US5230888A (en) * | 1982-05-06 | 1993-07-27 | Massachusetts Institute Of Technology | Production of neutralizing antibodies by polypeptide VP1 of enteroviruses and by oligopeptide fragments of polypeptide VP1 |
CA1271717A (fr) * | 1982-10-11 | 1990-07-17 | National Biological Standards Board | Polypeptides utiles dans la vaccination contre les enterovirus |
GB8301928D0 (en) * | 1983-01-24 | 1983-02-23 | Nicholson B H | Process for producing polypeptides |
AU573574B2 (en) * | 1983-03-08 | 1988-06-16 | Chiron Mimotopes Pty Ltd | Immunogenic deteminants of foot and mouth disease virus |
JPS60500673A (ja) * | 1983-03-08 | 1985-05-09 | コモンウエルス セラム ラボラトリ−ズ コミツシヨン | 抗原活性を有するアミノ酸配列 |
WO1984003506A1 (fr) * | 1983-03-08 | 1984-09-13 | Commw Serum Lab Commission | Sequences d'acides amines antigeniquement actives |
NZ207394A (en) * | 1983-03-08 | 1987-03-06 | Commw Serum Lab Commission | Detecting or determining sequence of amino acids |
AU576750B2 (en) * | 1983-03-08 | 1988-09-08 | Chiron Mimotopes Pty Ltd | Method of determining antigenically active amino acid sequences |
US4894332A (en) * | 1985-03-27 | 1990-01-16 | Biogen, Inc. | DNA sequences coding for Mycoplasma hypopneumoniae surface antigens, methods of use to make the corresponding proteins |
US4732971A (en) * | 1985-06-03 | 1988-03-22 | Eli Lilly And Company | Synthetic vaccines for foot and mouth disease |
US6074650A (en) * | 1985-06-24 | 2000-06-13 | Hoechst Aktiengesellschaft | Membrane anchor/active compound conjugate, its preparation and its uses |
DE3813821A1 (de) * | 1988-04-22 | 1989-11-02 | Hoechst Ag | Synthetische vakzine gegen die maul- und klauenseuche und verfahren zu deren herstellung |
US6024964A (en) * | 1985-06-24 | 2000-02-15 | Hoechst Aktiengesellschaft | Membrane anchor/active compound conjugate, its preparation and its uses |
WO1989005150A1 (fr) * | 1987-12-10 | 1989-06-15 | La Jolla Cancer Research Foundation | Peptides d'adhesion cellulaire a stabilisation conformationnelle |
US5827821A (en) * | 1987-12-10 | 1998-10-27 | The Burnham Institute | Conformationally stabilized cell adhesion peptides |
US5864008A (en) * | 1988-03-25 | 1999-01-26 | James; Stephen | Peptides derived from foot-and-mouth disease virus, pharmaceutical compositions, and methods for using the peptides |
EP0420913B1 (fr) * | 1988-06-14 | 1995-11-15 | Cell Med, Inc. | Reactifs immunologiques cellulaires heterofonctionnels, vaccins les contenant et leurs modes d'utilisation |
US5672585A (en) * | 1990-04-06 | 1997-09-30 | La Jolla Cancer Research Foundation | Method and composition for treating thrombosis |
US5780303A (en) * | 1990-04-06 | 1998-07-14 | La Jolla Cancer Research Foundation | Method and composition for treating thrombosis |
US5612311A (en) * | 1990-04-06 | 1997-03-18 | La Jolla Cancer Research Foundation | Method and composition for treating thrombosis |
AU660926B2 (en) * | 1990-04-06 | 1995-07-13 | La Jolla Cancer Research Foundation | Method and composition for treating thrombosis |
US5648330A (en) * | 1990-04-06 | 1997-07-15 | La Jolla Cancer Research Foundation | Method and composition for treating vascular graft occlusion |
US6521594B1 (en) | 1990-04-06 | 2003-02-18 | La Jolla Cancer Research Foundation | Method and composition for treating thrombosis |
DE19638044A1 (de) * | 1996-09-18 | 1998-03-19 | Bayer Ag | Immunogene Peptide von Maul- und Klauenseuchen-Viren |
CN105175516B (zh) * | 2009-06-04 | 2018-11-27 | 中牧实业股份有限公司 | 一种动物用肽疫苗及其制备 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT73021B (en) * | 1980-05-12 | 1983-10-19 | Biogen Nv | Process for producing dna sequences of recombinant dna molecules and polipeptides with specificyty on foot mouth disease as viral antigens |
EP0041767B1 (fr) * | 1980-06-06 | 1993-03-03 | Biogen, Inc. | Vecteurs améliorés, méthodes de construction de tels vecteurs et d'expression de gènes clonés |
FI83662C (fi) * | 1980-07-17 | 1991-08-12 | Scripps Clinic Res | Diagnostik antikropp och foerfarande foer dess framstaellning. |
NZ198388A (en) * | 1980-09-18 | 1985-05-31 | Wellcome Found | Dna molecule comprising sequence substantially corresponding to at least part of foot and mouth disease virus rna;transformed host cell;antigen and vaccine |
DK188582A (da) * | 1981-04-29 | 1982-10-30 | Biogen Nv | Bacillus-kloningsvektorer rekombinations-dna-molekyler bacillus-vaerter transformeret dermed samt fremgangsmaader til ekspressionaf fremmede dna-sekvenser og fremstilling af polypeptideer som er kodede dermed |
DE3382459D1 (de) * | 1982-04-14 | 1991-12-19 | James L Bittle | Kuenstliches pikornavirusantigen. |
EP0105481A1 (fr) * | 1982-09-30 | 1984-04-18 | The Wellcome Foundation Limited | Antigènes et vaccins contenant ces antigènes |
-
1983
- 1983-03-16 ZA ZA831854A patent/ZA831854B/xx unknown
- 1983-03-17 AU AU12553/83A patent/AU1255383A/en not_active Abandoned
- 1983-03-22 EP EP83301589A patent/EP0090581A3/fr not_active Withdrawn
- 1983-03-23 IL IL68201A patent/IL68201A0/xx unknown
- 1983-03-24 JP JP58048067A patent/JPS58213723A/ja active Pending
- 1983-03-25 US US06/478,901 patent/US4605512A/en not_active Expired - Fee Related
- 1983-03-25 NO NO831098A patent/NO831098L/no unknown
- 1983-03-25 ES ES520997A patent/ES8500997A1/es not_active Expired
- 1983-03-25 PT PT76451A patent/PT76451B/pt unknown
- 1983-03-25 DK DK139083A patent/DK139083A/da not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
PT76451A (en) | 1983-04-01 |
ZA831854B (en) | 1984-01-25 |
AU1255383A (en) | 1983-09-29 |
PT76451B (en) | 1986-03-11 |
EP0090581A2 (fr) | 1983-10-05 |
US4605512A (en) | 1986-08-12 |
DK139083A (da) | 1983-09-27 |
JPS58213723A (ja) | 1983-12-12 |
ES520997A0 (es) | 1984-11-01 |
EP0090581A3 (fr) | 1984-10-24 |
DK139083D0 (da) | 1983-03-25 |
ES8500997A1 (es) | 1984-11-01 |
NO831098L (no) | 1983-09-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL68201A0 (en) | Peptides with the specificity of foot and mouth disease viral antigens and compositions and methods for treating animals using the same | |
GB2102810B (en) | Human interferon-related peptides antigens antibodies and process for preparing the same | |
DE3379589D1 (en) | Enzyme composition for cleaning, the use thereof and preparation of the composition | |
NZ193487A (en) | Purification of human le form interferon proteins and antibodies thereto | |
LU90911I2 (fr) | Antig-ne recombinant comprenant les s-quences pre-S1 et S du virus de l'h-patite B ingr-dient actif de hepacare | |
GB2103622B (en) | Production of foot and mouth disease vaccine from microbially expressed antigens | |
EP0094575A3 (en) | Methods and materials for treatment of disease states involving immunological factors | |
GB9209718D0 (en) | Hcg-hlh receptor and hcg-hlh receptor-hch complex as antigens,antibodies thereto and contraceptive vaccine | |
DE3363642D1 (en) | Process for the preparation of protein hydrolysates | |
GB8304538D0 (en) | Antibodies and antigens | |
IL62833A0 (en) | Dna sequences recombinant dna molecules and processes for producing polypeptides with the specificity of foot and mouth disease viral antigens | |
JPS5726624A (en) | Isolation of virus glycoprotein antigen and manufacture of vaccine thereby | |
DE3378251D1 (en) | Vaccine for the immunization of animals and men against toxoplasma gondii | |
GB2079288B (en) | Dna sequences recombinat dna molecules and processes for producing polypeptides with the specificity of foot and mouth disease viral antigens | |
DK80584D0 (da) | Fremgangsmade til fremstilling af proteinholdigt dyrefoder og andre biprodukter ud fra cerealier og apparat til anvendelse ved udoevelse af fremgangsmaden | |
ZA824174B (en) | Production of foot and mouth disease vaccine from microbially expressed antigens thereof | |
GB2113998B (en) | Lactitol for the treatment of liver disease | |
JPS5589232A (en) | Vaccines against reo virus disease and their manufacture | |
ZW26082A1 (en) | Bivalent foot and mouth disease and colibacillose vaccine and method of preparing it | |
JPS6471488A (en) | Preparation of human immunodeficient virus type i antigen, and its use as diagnostic and curing agents | |
CS578887A1 (en) | Inactivated antigen of cattle's mucosal disease's virus | |
ZA828574B (en) | Bivalent foot and mouth disease and colibacillose vaccine and method of preparing it | |
DE3366025D1 (en) | Medicine for the treatment of the neoplazic disease | |
IL68559A (en) | Process for enhancing the level of physiologically active protein in an animal and compositions comprising physiologically active protein | |
NZ220611A (en) | 30 residue influenza virus peptide, vaccines and antibodies |